Mortality and Neurologic Outcomes in Rapid vs. Slow Hyponatremia Correction
NCT06675591 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2037
Last updated 2024-11-05
Summary
This study examines the impact of different rates of sodium correction on the outcomes of patients with severe hyponatremia (serum sodium ≤ 120 mEq/L). Hyponatremia is a condition where blood sodium levels are dangerously low, and its treatment must be carefully managed to avoid complications. Standard guidelines recommend correcting sodium levels slowly to prevent a rare but serious neurological condition called osmotic demyelination syndrome (ODS). However, recent evidence suggests that a faster rate of sodium correction may reduce hospital stay length and mortality without increasing the risk of ODS.
This retrospective study, conducted from 2010 to 2023 at a hospital in Buenos Aires, Argentina. It compares the outcomes of patients who had their sodium levels corrected rapidly (≥ 8 mEq/L in 24 hours) to those who had slower corrections. The primary outcomes measured are mortality and the development of ODS.
Conditions
- Hyponatremia
- Hospitalisation
- Mortality
- SEVERE HYPONATREMIA
Interventions
- OTHER
-
Rapid sodium correction
This study focuses on the exposure to different sodium correction rates in patients with severe hyponatremia (serum sodium ≤ 120 mEq/L) rather than an active intervention. The two key groups are defined by their rate of sodium correction during the first 24 hours of hospitalization: Rapid Sodium Correction: An increase in serum sodium of ≥ 8 mEq/L within 24 hours. Slow Sodium Correction: An increase in serum sodium of \< 8 mEq/L within 24 hours. The primary objective is to assess the association between these exposure rates and clinical outcomes, including in-hospital mortality, 30-day mortality, and the incidence of osmotic demyelination syndrome (ODS). This study differs from others by using a large, retrospective cohort of patients treated in a real-world clinical setting, spanning 13 years (2010-2023), and applying robust statistical adjustments such as propensity score analysis to control for confounders.
- OTHER
-
Slow sodium correction
This study focuses on the exposure to different sodium correction rates in patients with severe hyponatremia (serum sodium ≤ 120 mEq/L) rather than an active intervention. The two key groups are defined by their rate of sodium correction during the first 24 hours of hospitalization: Rapid Sodium Correction: An increase in serum sodium of ≥ 8 mEq/L within 24 hours. Slow Sodium Correction: An increase in serum sodium of \< 8 mEq/L within 24 hours. The primary objective is to assess the association between these exposure rates and clinical outcomes, including in-hospital mortality, 30-day mortality, and the incidence of osmotic demyelination syndrome (ODS). This study differs from others by using a large, retrospective cohort of patients treated in a real-world clinical setting, spanning 13 years (2010-2023), and applying robust statistical adjustments such as propensity score analysis to control for confounders.
Sponsors & Collaborators
-
University of California, Irvine
collaborator OTHER -
Hospital Privado de Comunidad de Mar del Plata
collaborator OTHER -
University of Pittsburgh
collaborator OTHER -
Hospital Italiano de Buenos Aires
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2024-04-30
- Completion
- 2024-05-01
Countries
- Argentina
More Related Trials
-
Tolvaptan for In-hospital Hyponatremia
NCT01386372 ·Status: TERMINATED ·Phase: PHASE2
-
Hyponatremia Volume Status Analysis by Point-of-care Ultrasound
NCT06013800 ·Status: ACTIVE_NOT_RECRUITING
-
0.9% NaCl/Dextrose 5% vs 0.45% NaCl/Dextrose 5% as Maintenance Intravenous Fluids in Critically Ill Children
NCT01301274 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Rapid Intermittent Compared With Slow Continuous Correction in Severe Hyponatremia Patients
NCT02887469 ·Status: COMPLETED ·Phase: PHASE4
-
Colloid Osmotic Pressure and Osmolality in Hyponatremia
NCT03703713 ·Status: TERMINATED
-
Efficacy and Safety of Rapid Intermittent Correction Compared With Slow Continuous Correction in Patients With Severe Hypernatremia
NCT04949139 ·Status: COMPLETED ·Phase: PHASE4
-
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
NCT01240668 ·Status: COMPLETED
-
Hypertonic Saline Solution in Heart Failure
NCT00555685 ·Status: COMPLETED ·Phase: PHASE2
-
Continuous Venovenous Hemofiltration Versus Conventional Treatment for Acute Severe Hypernatremia
NCT02449382 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Fluid Restriction in Congestive Heart Failure Complicated With Hyponatremia
NCT01748331 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Bolus Comparing With Continuous Drip of 3% NaCl in Patients With Severe Symptomatic Hyponatremia.
NCT04561531 ·Status: UNKNOWN ·Phase: NA
-
Once Versus Twice Daily Electrolyte Monitoring in CHF
NCT02497742 ·Status: COMPLETED ·Phase: NA
-
Prospective Analysis Into Development of Hypernatremia in Critically Ill Patients
NCT05085223 ·Status: UNKNOWN
-
Maintenance Intravenous Fluids in Children
NCT00621348 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Volume and Electrolyte Balance in Hyponatremia Treatment - a Prospective Observational Trial
NCT05692726 ·Status: RECRUITING
-
The Efficacy of Oral Versus Intravenous Hypertonic Saline Administration in Runners With Exercise-Associated Hyponatremia
NCT01110655 ·Status: UNKNOWN ·Phase: NA
-
Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
NCT01890694 ·Status: TERMINATED ·Phase: PHASE4
-
Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges
NCT06408077 ·Status: RECRUITING ·Phase: NA
-
Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT01909336 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Data Analysis of the Development of Hypernatremia in Intensive Care Unit
NCT03752450 ·Status: COMPLETED
-
Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients
NCT00727090 ·Status: TERMINATED ·Phase: PHASE4
-
Measurement of Serum Potassium Rate During Accidental Hypothermia.
NCT03096561 ·Status: UNKNOWN ·Phase: NA
-
Plasma Sodium and Sodium Administration in the ICU
NCT06037928 ·Status: UNKNOWN
-
Investigation on Differences in Skin Sodium Content Between Normal Subjects and ICU-patients
NCT02912299 ·Status: COMPLETED
-
Fluid Balance Neutralization During CRRT (Continuous Renal Replacement Therapy)
NCT04801784 ·Status: COMPLETED ·Phase: NA